Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Lateral Flow Assays Market Growth From $13.45 Billion In 2026 To $19.3 Billion By 2030 At A CAGR Of 9.5%#_x000D_
The lateral flow assays market has shown significant expansion in recent years. Its valuation is anticipated to increase from $12.29 billion in 2025 to $13.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. Throughout the preceding period, this market’s expansion was primarily propelled by factors including the escalating need for rapid diagnostic solutions, a broader scope of infectious disease testing, the widespread application of rapid test kits, the evolution of decentralized healthcare delivery, and increasing public awareness regarding early disease detection._x000D_
_x000D_
The lateral flow assays market is projected to experience substantial expansion over the upcoming years. This market is set to reach $19.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth during the forecast period is primarily driven by factors such as the rising uptake of home-based diagnostics, broader integration of digital health solutions, an escalating need for multiplex testing, increased funding into rapid diagnostic technologies, and a heightened emphasis on continuous disease monitoring. Key trends anticipated for this period encompass the growing acceptance of rapid point-of-care diagnostics, increased utilization of multiplex lateral flow assays, the expanding integration of digital LFA readers, the growth of veterinary and home-based testing applications, and an intensified focus on improving test sensitivity._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Lateral Flow Assays Market Industry Drivers: What’s Behind The Revenue Growth?#_x000D_
The widespread occurrence of infectious diseases globally significantly fuels the expansion of the lateral flow assay market. In developing countries, the frequent incidence of infectious diseases such as HIV and malaria, combined with inadequate healthcare systems and growing public awareness, is projected to accelerate the adoption of lateral flow assay testing. The recent COVID-19 pandemic has emphasized the necessity for early illness detection capabilities, which is expected to further drive market growth. For instance, in August 2024, data published by the UK Health Security Agency, a UK-based executive agency, indicated that in England, the UK Health Security Agency (UKHSA) recorded 368 measles cases in 2023. This figure represents a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands contributing 44% and London 33% of the cases, respectively. Therefore, the high prevalence of infectious diseases worldwide will continue to contribute to the growth of the lateral flow assay market._x000D_
_x000D_
#Lateral Flow Assays Market Segment Analysis Spotlighting Growth Areas#_x000D_
The lateral flow assays market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Kits And Reagents, Lateral Flow Readers _x000D_
2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays_x000D_
3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications_x000D_
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents _x000D_
2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers _x000D_
_x000D_
#Lateral Flow Assays Market Growth Trends: What’s Shaping The Future Outlook?_x000D_
Leading companies in the lateral flow assay market are concentrating on developing adaptable products, such as lateral flow readers, to facilitate on-the-go testing and establish a competitive advantage. A lateral flow reader is a compact instrument employed for the rapid and qualitative assessment of lateral flow assays, delivering effective results in various testing environments. For instance, in February 2024, Upfront Diagnostics, a UK-based healthcare company, introduced the Lateral Flow Test for Triaging Stroke Patients Next Year. This test, specifically designed for triaging stroke patients and known as LVOne, aims to considerably boost the speed and accuracy of stroke diagnosis in pre-hospital settings. The LVOne test is a rapid blood test that enables paramedics to detect strokes caused by large vessel occlusions (LVO) within 15 minutes. This swift identification is essential for promptly directing patients to specialized stroke centers where timely treatment can dramatically enhance outcomes and mitigate long-term disabilities._x000D_
_x000D_
#Lateral Flow Assays Market Top Companies Driving Competitive Growth#_x000D_
Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics _x000D_
_x000D_
#View The Full Lateral Flow Assays Market Report:#_x000D_
_x000D_
#Lateral Flow Assays Market Global Footprint: Which Region Leads The Market?#_x000D_
North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model